Bank of America Issues Pessimistic Forecast for International Flavors & Fragrances (NYSE:IFF) Stock Price

International Flavors & Fragrances (NYSE:IFF) had its price target lowered by Bank of America from $105.00 to $101.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a buy rating on the specialty chemicals company’s stock.

Several other brokerages have also weighed in on IFF. Vertical Research raised International Flavors & Fragrances from a “hold” rating to a “buy” rating and set a $109.00 price objective on the stock in a report on Thursday, November 7th. Argus raised shares of International Flavors & Fragrances from a “hold” rating to a “buy” rating in a report on Tuesday, January 7th. Wells Fargo & Company reduced their price objective on shares of International Flavors & Fragrances from $115.00 to $105.00 and set an “overweight” rating for the company in a report on Thursday. Stifel Nicolaus lowered their target price on shares of International Flavors & Fragrances from $113.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Finally, Cfra lowered shares of International Flavors & Fragrances from a “buy” rating to a “sell” rating and set a $77.00 price target for the company. in a research report on Thursday. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $103.50.

International Flavors & Fragrances Trading Down 0.3 %

Shares of IFF stock opened at $79.92 on Thursday. The company has a current ratio of 1.84, a quick ratio of 1.93 and a debt-to-equity ratio of 0.54. International Flavors & Fragrances has a 1 year low of $72.94 and a 1 year high of $106.77. The firm’s fifty day simple moving average is $84.71 and its 200 day simple moving average is $93.43. The firm has a market capitalization of $20.43 billion, a P/E ratio of 85.02, a price-to-earnings-growth ratio of 1.45 and a beta of 1.19.

International Flavors & Fragrances (NYSE:IFF) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.14. International Flavors & Fragrances had a net margin of 2.12% and a return on equity of 7.72%. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.67 billion. As a group, sell-side analysts predict that International Flavors & Fragrances will post 4.32 EPS for the current year.

Institutional Trading of International Flavors & Fragrances

Several large investors have recently made changes to their positions in the business. SBI Securities Co. Ltd. acquired a new position in International Flavors & Fragrances during the 4th quarter worth about $32,000. Point72 Hong Kong Ltd bought a new position in shares of International Flavors & Fragrances in the third quarter worth about $42,000. Fairway Wealth LLC acquired a new position in shares of International Flavors & Fragrances during the fourth quarter worth approximately $34,000. Eastern Bank bought a new stake in shares of International Flavors & Fragrances during the third quarter valued at approximately $46,000. Finally, Ashton Thomas Securities LLC acquired a new stake in shares of International Flavors & Fragrances in the third quarter valued at approximately $48,000. Institutional investors own 96.02% of the company’s stock.

International Flavors & Fragrances Company Profile

International Flavors & Fragrances, Inc engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division.